e-learning
resources
Vienna 2012
Monday, 03.09.2012
Cell biology, blood and sputum biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis
P. Goeminne, J. Vandooren, A. Pauwels, A. Decraene, G. Opdenakker, L. Dupont (Leuven, Belgium)
Source:
Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Session:
Cell biology, blood and sputum biomarkers in airway diseases
Session type:
Thematic Poster Session
Number:
2236
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Goeminne, J. Vandooren, A. Pauwels, A. Decraene, G. Opdenakker, L. Dupont (Leuven, Belgium). Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis. Eur Respir J 2012; 40: Suppl. 56, 2236
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Physical activity evaluation in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017
Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Exacerbations in non cystic fibrosis bronchiectasis: clinical features and investigations
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
Demographics and characteristics of antibiotic use in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Clinical and functional profile of patients with non-cystic fibrosis bronchiectasis according to the presence of chronic bronchial infection
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
The effect of gender on sputum microbiological profile in non-cystic fibrosis bronchiectasis
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Phenotype characterization of non-cystic fibrosis bronchiectasis in India.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
The relationship of walking speed with clinical parameters in patients with non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020
Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018
Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010
Coronaphobia and physical activity level in patients with non-cystic fibrosis bronchiectasis during COVID-19 pandemic
Source: Virtual Congress 2021 – Symptoms across respiratory diseases and impact of COVID-19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept